![(+)-3,4,4a,5,6,10b-Hexahydro-9-methoxy-2H-naphtho[1,2-b][1,4]oxazin, HCl - chemical structure image](https://media.scbt.com/product/plus-3-4-4a-5-6-10b-hexahydro-9-methoxy-2h-naphtho1-2-b1-4oxazin-hcl-structure_26_21_b_262154.jpg)
![(+)-3,4,4a,5,6,10b-Hexahydro-9-methoxy-2H-naphtho[1,2-b][1,4]oxazin, HCl - chemical structure image](https://media.scbt.com/product/plus-3-4-4a-5-6-10b-hexahydro-9-methoxy-2h-naphtho1-2-b1-4oxazin-hcl-structure_26_21_t_262154.jpg "Molecular structure of (+)-3,4,4a,5,6,10b-Hexahydro-9-methoxy-2H-naphtho[1,2-b][1,4]oxazin, HCl")
Molecular structure of (+)-3,4,4a,5,6,10b-Hexahydro-9-methoxy-2H-naphtho[1,2-b][1,4]oxazin, HCl
(+)-3,4,4a,5,6,10b-Hexahydro-9-methoxy-2H-naphtho[1,2-b][1,4]oxazin, HCl
Application:
(+)-3,4,4a,5,6,10b-Hexahydro-9-methoxy-2H-naphtho[1,2-b][1,4]oxazin, HCl is a dopamine receptor antagonist
Molecular Weight:
255.74
Molecular Formula:
C13H18ClNO2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
A dopamine antagonist and dopaminergic ligand.
(+)-3,4,4a,5,6,10b-Hexahydro-9-methoxy-2H-naphtho[1,2-b][1,4]oxazin, HCl References
Dijkstra, D., et al.: J. Med. Chem., 45, 3022 (2002)Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
(+)-3,4,4a,5,6,10b-Hexahydro-9-methoxy-2H-naphtho[1,2-b][1,4]oxazin, HCl, 5 mg | sc-216590 | 5 mg | $330.00 |